LARIMAR THERAPEUTICS INC (LRMR)
US5171251003 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 110.13M | 26.75M | 26.80M | 70.10M | 68.10M | |||
| Marketable Securities | 117.17M | 60.04M | 91.60M | 0.00 | 24.50M | |||
| Receivables | 1.08M | N/A | 0.00 | 200.00K | N/A | |||
| Other Current Assets | 2.58M | 3.38M | 2.30M | 1.90M | 5.30M | |||
| Total Current Assets | 230.95M | 90.17M | 120.70M | 72.20M | 98.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.52M | 3.76M | 3.70M | 4.50M | 5.00M | |||
| Investments And Advances | 11.71M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.02M | 2.00M | 2.00M | 2.00M | 1.80M | |||
| Total Non-Current Assets | 17.25M | 5.76M | 5.70M | 6.50M | 6.70M | |||
| TOTAL ASSETS | 248.21M | 95.94M | 126.40M | 78.70M | 104.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 10.92M | 8.22M | 9.00M | 7.20M | 6.40M | |||
| Accounts Payable | 1.92M | 1.28M | 1.70M | 1.70M | 2.60M | |||
| Total Current Liabilities | 12.84M | 9.51M | 10.70M | 8.80M | 9.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.52M | 4.71M | 4.80M | 5.40M | 6.00M | |||
| Total Non-Current Liabilities | 4.52M | 4.71M | 4.80M | 5.50M | 6.00M | |||
| TOTAL LIABILITIES | 17.36M | 14.21M | 15.50M | 14.30M | 15.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -203.21M | -188.55M | -151.60M | -116.30M | -65.60M | |||
| Additional Paid In Capital | 434.01M | 270.15M | 262.50M | 180.60M | 155.30M | |||
| Common Shares | 64.00K | 43.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -25.00K | 81.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 63.80M | 43.91M | 43.30M | 17.70M | 15.40M | |||
| Tangible Book Value per Share | 3.62 | 1.86 | 2.56 | 3.64 | 5.82 | |||
| Total Shareholders' Equity | 230.84M | 81.72M | 110.90M | 64.40M | 89.70M | |||
| TOTAL LIABILITIES AND EQUITY | 248.21M | 95.94M | 126.40M | 78.70M | 104.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 17.99 | 9.49 | 11.28 | 8.20 | 10.89 | |||
| Return On Assets (ROA) | -18.16% | -38.51% | -27.97% | -64.35% | -40.57% | |||
| Return On Equity (ROE) | -19.53% | -45.21% | -31.88% | -78.63% | -47.36% | |||
All data in USD